91Ó°ÊÓ

Researchers at the University of Washington and Harvard University analyzed records of breast cancer screening and diagnostic evaluations ("Mammogram Cancer Scares More Frequent than Thought," USA Today. April 16, 1998). Discussing the benefits and downsides of the screening process, the article states that, although the rate of false-positives is higher than previously thought, if radiologists were less aggressive in following up on suspicious tests, the rate of false-positives would fall but the rate of missed cancers would rise. Suppose that such a screening test is used to decide between a null hypothesis of \(H_{0}:\) no cancer is present and an alternative hypothesis of \(H_{a}\) : cancer is present. (Although these are not hypotheses about a population characteristic, this exercise illustrates the definitions of Type I and Type II errors.) a. Would a false-positive (thinking that cancer is present when in fact it is not) be a Type I error or a Type II error? b. Describe a Type I error in the context of this problem, and discuss the consequences of making a Type I error. c. Describe a Type II error in the context of this problem, and discuss the consequences of making a Type II error. d. What aspect of the relationship between the probability of Type I and Type II errors is being described by the statement in the article that if radiologists were less aggressive in following up on suspicious tests, the rate of false-positives would fall but the rate of missed cancers would rise?

Step by step solution

01

Identify the Type of Error for False-Positive Test Results

A false-positive result refers to a situation when the test wrongly indicates the presence of cancer (rejecting the null hypothesis \(H_{0}\) when it is true). This is an example of a Type I error.

02

Describe Type I Error and its Consequences

A Type I error in this context is when the screening test wrongly indicates that a patient has cancer (the null hypothesis \(H_{0}\) of no cancer being present is wrongly rejected). The consequences of this error can be severe; it can be emotionally distressing for the patient and lead to unnecessary and potentially harmful treatments.

03

Describe Type II Error and its Consequences

A Type II error in this context is when the screening test wrongly indicates that a patient does not have cancer (the alternative hypothesis \(H_{a}\) of cancer being present is incorrectly rejected). The consequences of this error could potentially be fatal; it means that cancer goes undetected and untreated, leading to worsening of the patient's condition.

04

Understand the Relationship between Type I and Type II Errors

The statement from the article suggests that radiologists being less aggressive in diagnosing suspicious tests (i.e., being more cautious about false-positives) would decrease Type I errors (false-positives) but would increase Type II errors (missed detections of cancer). This illustrates a trade-off between Type I and Type II errors - reducing the probability of one kind of error often increases the likelihood of the other type.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Type I Error

In hypothesis testing, a Type I error occurs when the null hypothesis is rejected even though it is true. In simpler terms, it's a false alarm. We say there is an effect or condition when there isn't one. Regarding breast cancer screening, a Type I error happens when a test indicates the presence of cancer when, in reality, there is none. The consequences of a Type I error in this scenario can be significant. For starters, it can lead to undue stress and anxiety for the patient, as they are mistakenly informed of having cancer. Besides the emotional impact, there are practical implications as well.

• The patient may undergo unnecessary treatments, which can have side effects and pose health risks.
• It can incur additional medical costs for both the patient and the healthcare system.

Understanding Type I errors is crucial, particularly in medical testing, where the implications can extend to both physical and emotional health.

Type II Error

A Type II error in hypothesis testing is when the null hypothesis is not rejected though it is false. This error means missing a true effect or condition, often referred to as a missed detection. In the context of breast cancer screenings, a Type II error would occur if the test fails to detect cancer that is actually present. The stakes with a Type II error can be even higher than those with a Type I error. Why? Because failing to detect cancer could mean:

• The disease progresses without treatment, which can be life-threatening.
• The opportunity for early intervention and effective treatment is lost, potentially worsening the patient's prognosis.

Type II errors highlight the critical need for sensitive and accurate tests to ensure that truly afflicted patients receive necessary care promptly.

False Positives

False positives are often associated with Type I errors. In medical testing, such as breast cancer screenings, a false positive result incorrectly indicates that a condition is present. Having a high rate of false positives in medical tests can lead to several problems, such as:

• Causing distress and anxiety to patients who are told they have a serious illness when they do not.
• Leading to unnecessary follow-up tests, procedures, and treatments.
• Burdens on the healthcare system due to extra time and resources being used for further testing and treatment of non-existent conditions.

Hence, balancing the accuracy and sensitivity of tests is vital to reduce false positives while ensuring conditions are not missed.

Screening Tests

Screening tests, particularly in the medical field, are designed to detect potential diseases or conditions in individuals without symptoms. These tests must strike a balance between sensitivity and specificity.

• Sensitivity refers to a test's ability to correctly identify those with the disease (true positives).
• Specificity refers to a test's ability to correctly identify those without the disease (true negatives).

The article discussion highlights a crucial aspect of screening tests: the trade-off between sensitivity and specificity. If radiologists become less aggressive following suspicious tests, this may reduce the rate of false positives but could increase false negatives (Type II errors), leading to missed cancers. This balancing act between different types of errors necessitates careful calibration based on the test's goals and the severity of the condition being screened for. Effective screening tests are essential as they pave the way for early intervention and management of diseases, improving outcomes and saving lives.